TGFB1 and pemphigus foliaceus: Finally, targeting these molecules might also have a particular therapeutic value, such as TGF-β blockade with antibodies, inhibitors, or agonists, to reverse its effects that could reduce morbidity and prevent long-term sequela such as PF development.